Johnson & Johnson Rules Out Big Acquisitions, Reiterates Focus On Small Deals: Analyst

benzinga.com/analyst-stock-ratings/analyst-color/25/10/48234008/johnson-johnson-rules-out-big-acquisitions-reiterates-focus-on-small-deals-an

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating the consensus of $2.75.
JNJ is trading at elevated levels. See what the experts say here.
Johnson & Johnson also announced plans to separate its…

This story appeared on benzinga.com, 2025-10-15 17:56:28.
The Entire Business World on a Single Page. Free to Use →